publication date: Dec. 19, 2010

In this issue: 

FDA approves Gemzar for ovarian cancer, contradicting ODAC recommendation; continues agency trend to recognize progression-free survival as an endpoint.

FDA official says acceptance of PFS “brings us in line with our European colleagues.”

NCI says sponsored meetings must be held in smoke-free localities as of Jan. 1.

ACS presents awards to anti-tobacco activists.

Download (PDF 763KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.